生物标志物 生物标志物
Carla Palleis1,2,3, Nicolai Franzmeier4,5,6,7, Johannes Gnörich2
1German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
F-PI-2620 tau-PET成像通过识别4重复的tau (4RT) 病理来帮助诊断渐进性超核麻 (PSP). 这种生物标志物显示出早期,更准确的PSP诊断和临床试验患者分层的潜力.
科学领域:
- 神经科学是一个神经科学.
- 放射学 放射学是一门学科.
- 神经病理学神经病理学
背景情况:
- 渐进性超核性 (PSP) 是一种具有挑战性的四重复性病,具有异质的临床表现.
- 目前用于PSP诊断的临床标准缺乏敏感性和特异性,特别是在早期阶段.
- F-PI-2620 tau-PET 是一种新兴的体内成像生物标志物,用于检测4重复的tau (4RT) 沉积物.
研究的目的:
- 评估F-PI-2620 tau-PET在诊断PSP中的临床实用性.
- 确定由F-PI-2620 tau-PET评估的4RT阳性是否预测PSP的诊断确定性增加.
主要方法:
- 慕尼黑LMU医院的一项前性,单心的队列研究 (2018年10月 - 2024年12月).
- 包括342名患有PSP的PET前差异诊断的患者.
- F-PI-2620 tau-PET成像与专家视觉评估的4RT病理和临床后续 (12-24个月).
主要成果:
- 在200名随访患者中,137人 (68.5%) 通过tau-PET获得4RT阳性.
- 18F-PI-2620 tau-PET 正确识别了沿着4RT临床光谱进展的患者.
- 79%的tau-PET阳性患者显示PSP的诊断确定性增加,而95.5%的非PSP诊断与负tau-PET有关.
结论:
- F-PI-2620 tau-PET有效地识别了与PSP进展一致的4RT病理的患者.
- 这种tau-PET追踪器支持基于生物标志物的诊断,比单纯的临床标准提高了灵敏度和特异性.
- F-PI-2620 tau-PET可以改变PSP诊断,使得早期检测和患者分层进行试验.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516